Evangelos Oikonomou is a Cardiology physician affiliated with Yale University. OpenAlex indexes 240 publications with 8,585 citations (h-index 41).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
20 York St
New Haven, CT 065103220
Telephone
203-688-4242Provider last certified this registry record 25 Apr 2025.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20232 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
79.9%Statin17.3%Rosuvastatin Calcium100%Part D<11 patientsAngiotensin receptor-neprilysin inhibitor (ARNI)17.3%Entresto100%Part D<11 patients+ 6 more classes in this area
Blood & clotting
12.8%Factor Xa inhibitor12.8%Eliquis100%Part D<11 patientsMetabolism & gastrointestinal
7.3%SGLT2 inhibitor7.3%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2023–2026 per NIH RePORTER. The latest:
- TARGET-TTR: Targeted Artificial Intelligence-Driven Screening of Transthyretin Amyloid Cardiomyopathy in the Electronic Health Record
Yale University
FY2026$170,964K23HL181318 - A multi-modal approach for efficient, point-of-care screening of hypertrophic cardiomyopathy
Yale University
FY2024$86,392F32HL170592 - A multi-modal approach for efficient, point-of-care screening of hypertrophic cardiomyopathy
Yale University
FY2024$3,000F32HL170592
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Ensemble Deep Learning Algorithm for Structural Heart Disease Screening Using Electrocardiographic Images
Journal of the American College of Cardiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
John Krystal, MD
Yale University
Lajos Pusztai, MD
Yale University
Lee Schwamm, MD
Yale University
Naftali Kaminski, MD
Yale University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”